nach oben

Erschienen in:

01.03.2010 | Review

Genetics of early-onset obsessive–compulsive disorder

verfasst von: Susanne Walitza, Jens R. Wendland, Edna Gruenblatt, Andreas Warnke, Thomas A. Sontag, Oliver Tucha, Klaus W. Lange

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Obsessive–compulsive disorder (OCD) is characterized by recurrent, intrusive and disturbing thoughts as well as by repetitive stereotypic behaviors. Epidemiological data are similar in children and adults, i.e., between 1 and 3% of the general population suffer from OCD. Children with OCD are often seriously impaired in their development. OCD, especially of early onset, has been shown to be familial. Several candidate genes of predominantly neurotransmitter systems have been analyzed and a total of three genome-wide linkage scans have been performed until now. Analyses of candidate genes in linkage regions have not provided evidence for their involvement in OCD, with the exception of the glutamate transporter gene SLC1A1 on 9p24. Genome-wide association analyses are in progress and the results will promote further independent replication studies. The consideration of subtypes regarding age of onset, symptom dimensions and/or comorbid disorders is needed.

Albert U, Maina G, Ravizza L, Bogetto F (2002) An exploratory study on obsessive–compulsive disorder with and without a familial component: are there any phenomenological differences? Psychopathology 35:8–16CrossRefPubMed

Alonso P, Gratacos M, Menchon JM, Saiz-Ruiz J, Segalas C, Baca-Garcia E, Labad J, Fernandez-Piqueras J, Real E, Vaquero C, Perez M, Dolengevich H, Gonzalez JR, Bayes M, de Cid R, Vallejo J, Estivill X (2008) Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive–compulsive disorder. Biol Psychiatry 63:619–628CrossRefPubMed

Aouizerate B, Guehl D, Cuny E, Rougier A, Burbaud P, Tignol J, Bioulac B (2005) Updated overview of the putative role of the serotoninergic system in obsessive–compulsive disorder. Neuropsychiatric Dis Treat 1:231–243

Aoyama K, Suh SW, Hamby AM, Liu J, Chan WY, Chen Y, Swanson RA (2006) Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci 9:119–126CrossRefPubMed

Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA (2004) Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive–compulsive disorder: a preliminary study. Psychopharmacology (Berl) 174:530–538CrossRef

Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL (2006) Glutamate transporter gene SLC1A1 associated with obsessive–compulsive disorder. Arch Gen Psychiatry 63:769–776CrossRefPubMed

Bellodi L, Sciuto G, Diaferia G, Ronchi P, Smeraldi E (1992) Psychiatric disorders in the families of patients with obsessive–compulsive disorder. Psychiatry Res 42:111–120CrossRefPubMed

Black DW, Noyes R Jr, Goldstein RB, Blum N (1992) A family study of obsessive–compulsive disorder. Arch Gen Psychiatry 49:362–368PubMed

Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF (2008) Meta-analysis of the symptom structure of obsessive–compulsive disorder. Am J Psychiatry 165:1532–1542CrossRefPubMed

10.

Bolton D, Rijsdijk F, O’Connor TG, Perrin S, Eley TC (2007) Obsessive–compulsive disorder, tics and anxiety in 6-year-old twins. Psychol Med 37:39–48CrossRefPubMed

11.

Chabane N, Delorme R, Millet B, Mouren MC, Leboyer M, Pauls D (2005) Early-onset obsessive–compulsive disorder: a subgroup with a specific clinical and familial pattern? J Child Psychol Psychiatry 46:881–887CrossRefPubMed

12.

Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S (2005) Glutamatergic dysfunction in OCD. Neuropsychopharmacology 30:1735–1740CrossRefPubMed

13.

Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL (2006) Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive–compulsive disorder. Arch Gen Psychiatry 63:778–785CrossRefPubMed

14.

do Rosario-Campos MC, Leckman JF, Curi M, Quatrano S, Katsovitch L, Miguel EC, Pauls DL (2005) A family study of early-onset obsessive–compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 136B:92–97CrossRefPubMed

15.

Eley TC, Bolton D, O’Connor TG, Perrin S, Smith P, Plomin R (2003) A twin study of anxiety-related behaviours in pre-school children. J Child Psychol Psychiatry 44:945–960CrossRefPubMed

16.

Enoch MA, Goldman D, Barnett R, Sher L, Mazzanti CM, Rosenthal NE (1999) Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, −1438G/A. Mol Psychiatry 4:89–92CrossRefPubMed

17.

Enoch MA, Greenberg BD, Murphy DL, Goldman D (2001) Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive–compulsive disorder. Biol Psychiatry 49:385–388CrossRefPubMed

18.

Flament MF, Whitaker A, Rapoport JL, Davies M, Berg CZ, Kalikow K, Sceery W, Shaffer D (1988) Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry 27:764–771CrossRefPubMed

19.

Grados M, Wilcox HC (2007) Genetics of obsessive–compulsive disorder: a research update. Expert Rev Neurother 7:967–980CrossRefPubMed

20.

Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M (2003) Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive–compulsive disorder. Am J Hum Genet 73:370–376CrossRefPubMed

21.

Hanna GL, Himle JA, Curtis GC, Gillespie BW (2005) A family study of obsessive–compulsive disorder with pediatric probands. Am J Med Genet B Neuropsychiatr Genet 134B:13–19CrossRefPubMed

22.

Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, Leventhal BL, Cook EH Jr (2002) Genome-wide linkage analysis of families with obsessive–compulsive disorder ascertained through pediatric probands. Am J Med Genet 114:541–552CrossRefPubMed

23.

Hanna GL, Veenstra-Vanderweele J, Cox NJ, Van Etten M, Fischer DJ, Himle JA, Bivens NC, Wu X, Roe CA, Hennessy KA, Dickel DE, Leventhal BL, Cook EH Jr (2007) Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive–compulsive disorder. Biol Psychiatry 62:856–862CrossRefPubMed

24.

Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621–2624PubMed

25.

Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive–compulsive disorder. Am J Hum Genet 78:815–826CrossRefPubMed

26.

Hudziak JJ, Van Beijsterveldt CE, Althoff RR, Stanger C, Rettew DC, Nelson EC, Todd RD, Bartels M, Boomsma DI (2004) Genetic and environmental contributions to the Child Behavior Checklist Obsessive–Compulsive Scale: a cross-cultural twin study. Arch Gen Psychiatry 61:608–616CrossRefPubMed

27.

Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593–602CrossRefPubMed

28.

Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241–247CrossRefPubMed

29.

Leckman JF, Zhang H, Alsobrook JP, Pauls DL (2001) Symptom dimensions in obsessive–compulsive disorder: toward quantitative phenotypes. Am J Med Genet 105:28–30CrossRefPubMed

30.

Lenane MC, Swedo SE, Leonard H, Pauls DL, Sceery W, Rapoport JL (1990) Psychiatric disorders in first-degree relatives of children and adolescents with obsessive compulsive disorder. J Am Acad Child Adolesc Psychiatry 29:407–412CrossRefPubMed

31.

Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527–1531CrossRefPubMed

32.

Liang KY, Wang Y, Shugart YY, Grados M, Fyer AJ, Rauch S, Murphy D, McCracken J, Rasmussen S, Cullen B, Hoehn-Saric R, Greenberg B, Pinto A, Knowles J, Piacentini J, Pauls D, Bienvenu O, Riddle M, Samuels J, Nestadt G (2008) Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive–compulsive disorder with compulsive hoarding. Am J Med Genet B Neuropsychiatr Genet 147B:1000–1002CrossRefPubMed

33.

Lochner C, Hemmings SM, Kinnear CJ, Nel D, Seedat S, Moolman-Smook JC, Stein DJ (2008) Cluster analysis of obsessive–compulsive symptomatology: identifying obsessive–compulsive disorder subtypes. Isr J Psychiatry Relat Sci 45:164–176PubMed

34.

Miguel EC, Leckman JF, Rauch S, do Rosario-Campos MC, Hounie AG, Mercadante MT, Chacon P, Pauls DL (2005) Obsessive–compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 10:258–275CrossRefPubMed

35.

Mossner R, Walitza S, Geller F, Scherag A, Gutknecht L, Jacob C, Bogusch L, Remschmidt H, Simons M, Herpertz-Dahlmann B, Fleischhaker C, Schulz E, Warnke A, Hinney A, Wewetzer C, Lesch KP (2006) Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive–compulsive disorder. Int J Neuropsychopharmacol 9:437–442CrossRefPubMed

36.

Mossner R, Walitza S, Lesch KP, Geller F, Barth N, Remschmidt H, Hahn F, Herpertz-Dahlmann B, Fleischhaker C, Schulz E, Warnke A, Hinney A, Wewetzer C (2005) Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive–compulsive disorder. Int J Neuropsychopharmacol 8:133–136CrossRefPubMed

37.

Murphy DL, Lesch KP (2008) Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci 9:85–96CrossRefPubMed

38.

Nestadt G, Samuels J, Riddle M, Bienvenu OJ 3rd, Liang KY, LaBuda M, Walkup J, Grados M, Hoehn-Saric R (2000) A family study of obsessive–compulsive disorder. Arch Gen Psychiatry 57:358–363CrossRefPubMed

39.

Nicolini H, Weissbecker K, Mejia JM, Sanchez de Carmona M (1993) Family study of obsessive–compulsive disorder in a Mexican population. Arch Med Res 24:193–198PubMed

40.

Palladino MJ, Keegan LP, O’Connell MA, Reenan RA (2000) dADAR, a drosophila double-stranded RNA-specific adenosine deaminase is highly developmentally regulated and is itself a target for RNA editing. RNA 6:1004–1018CrossRefPubMed

41.

Pauls DL (2008) The genetics of obsessive compulsive disorder: a review of the evidence. Am J Med Genet C Semin Med Genet 148C:133–139CrossRefPubMed

42.

Pauls DL, Alsobrook JP 2nd, Goodman W, Rasmussen S, Leckman JF (1995) A family study of obsessive–compulsive disorder. Am J Psychiatry 152:76–84PubMed

43.

Pittenger C, Krystal JH, Coric V (2006) Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive–compulsive disorder. NeuroRx 3:69–81CrossRefPubMed

44.

Reddy PS, Reddy YC, Srinath S, Khanna S, Sheshadri SP, Girimaji SR (2001) A family study of juvenile obsessive–compulsive disorder. Can J Psychiatry 46:346–351PubMed

45.

Riddle MA, Scahill L, King R, Hardin MT, Towbin KE, Ort SI, Leckman JF, Cohen DJ (1990) Obsessive compulsive disorder in children and adolescents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry 29:766–772PubMedCrossRef

46.

Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Page J, Rasmussen SA, Bienvenu OJ, Hoehn-Saric R, Valle D, Liang KY, Riddle MA, Nestadt G (2006) Genomewide linkage scan for obsessive–compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11:763–770CrossRefPubMed

47.

Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, Jenike E, Chabane N, Leboyer M, Delorme R, Jenike MA, Pauls DL (2007) Association of the SLC1A1 glutamate transporter gene and obsessive–compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 144B:1027–1033CrossRefPubMed

48.

Stewart SE, Geller DA, Jenike M, Pauls D, Shaw D, Mullin B, Faraone SV (2004) Long-term outcome of pediatric obsessive–compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand 110:4–13CrossRefPubMed

49.

Valleni-Basile LA, Garrison CZ, Jackson KL, Waller JL, McKeown RE, Addy CL, Cuffe SP (1994) Frequency of obsessive–compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry 33:782–791CrossRefPubMed

50.

van Grootheest DS, Cath DC, Beekman AT, Boomsma DI (2005) Twin studies on obsessive–compulsive disorder: a review. Twin Res Hum Genet 8:450–458PubMed

51.

Veenstra-VanderWeele J, Kim SJ, Gonen D, Hanna GL, Leventhal BL, Cook EH Jr (2001) Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive–compulsive disorder. Mol Psychiatry 6:160–167CrossRefPubMed

52.

Walitza S, Scherag A, Renner TJ, Hinney A, Remschmidt H, Herpertz-Dahlmann B, Schulz E, Schafer H, Lange KW, Wewetzer C, Gerlach M (2008) Transmission disequilibrium studies in early onset of obsessive–compulsive disorder for polymorphisms in genes of the dopaminergic system. J Neural Transm 115:1071–1078CrossRefPubMed

53.

Walitza S, Wewetzer C, Gerlach M, Klampfl K, Geller F, Barth N, Hahn F, Herpertz-Dahlmann B, Gossler M, Fleischhaker C, Schulz E, Hebebrand J, Warnke A, Hinney A (2004) Transmission disequilibrium studies in children and adolescents with obsessive–compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. J Neural Transm 111:817–825CrossRefPubMed

54.

Walitza S, Wewetzer C, Warnke A, Gerlach M, Geller F, Gerber G, Gorg T, Herpertz-Dahlmann B, Schulz E, Remschmidt H, Hebebrand J, Hinney A (2002) 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive–compulsive disorders. Mol Psychiatry 7:1054–1057CrossRefPubMed

55.

Wendland JR, Kruse MR, Cromer KR, Murphy DL (2007) A large case–control study of common functional SLC6A4 and BDNF variants in obsessive–compulsive disorder. Neuropsychopharmacology 32:2543–2551CrossRefPubMed

56.

Wendland JR, Moya PR, Timpano KR, Anavitarte AP, Kruse MR, Wheaton MG, Ren-Patterson RF, Murphy DL (2009) A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive–compulsive disorder. Arch Gen Psychiatry 66:408–416CrossRefPubMed

57.

Wendland JR, Nalls MA, Moya PR, Murphy DL, McMahon FJ, Remschmidt H, Herpertz-Dahlmann B, Schulz E, Renner TJ, Walitza S (2010, under review) Trio study and support the association of the serotonin transporter 5-HTTLPR gain-of-functional allele with obsessive–compulsive disorder

58.

Willour VL, Yao Shugart Y, Samuels J, Grados M, Cullen B, Bienvenu OJ 3rd, Wang Y, Liang KY, Valle D, Hoehn-Saric R, Riddle M, Nestadt G (2004) Replication study supports evidence for linkage to 9p24 in obsessive–compulsive disorder. Am J Hum Genet 75:508–513CrossRefPubMed

59.

Zai G, Bezchlibnyk YB, Richter MA, Arnold P, Burroughs E, Barr CL, Kennedy JL (2004) Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive–compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 129B:64–68CrossRefPubMed

Titel: Genetics of early-onset obsessive–compulsive disorder
verfasst von: Susanne Walitza
Jens R. Wendland
Edna Gruenblatt
Andreas Warnke
Thomas A. Sontag
Oliver Tucha
Klaus W. Lange
Publikationsdatum: 01.03.2010
Verlag: Springer-Verlag
Erschienen in: European Child & Adolescent Psychiatry / Ausgabe 3/2010
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-010-0087-7

Neu im Fachgebiet Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Genetics of early-onset obsessive–compulsive disorder

Abstract

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

From nature versus nurture, via nature and nurture, to gene × environment interaction in mental disorders

Molecular genetics of attention-deficit/hyperactivity disorder: an overview

Genetics of developmental dyslexia

Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder

Genetics of autistic disorders: review and clinical implications

Child and adolescent psychiatric genetics

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie